LifeStance Health Group I... (LFST)
LifeStance Health Statistics
Share Statistics
LifeStance Health has 388.88M shares outstanding. The number of shares has increased by 0.59% in one year.
| Shares Outstanding | 388.88M |
| Shares Change (YoY) | 0.59% |
| Shares Change (QoQ) | 0.5% |
| Owned by Institutions (%) | 88.89% |
| Shares Floating | 117.17M |
| Failed to Deliver (FTD) Shares | 41 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 9.32M, so 2.4% of the outstanding shares have been sold short.
| Short Interest | 9.32M |
| Short % of Shares Out | 2.4% |
| Short % of Float | 10.81% |
| Short Ratio (days to cover) | 4.53 |
Valuation Ratios
The PE ratio is -48.64 and the forward PE ratio is null. LifeStance Health's PEG ratio is 0.69.
| PE Ratio | -48.64 |
| Forward PE | n/a |
| PS Ratio | 2.23 |
| Forward PS | 1.4 |
| PB Ratio | 1.93 |
| P/FCF Ratio | 32.61 |
| PEG Ratio | 0.69 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for LifeStance Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.37 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 12.17 |
| Debt / FCF | 5.66 |
| Interest Coverage | -1.19 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $122.43K |
| Profits Per Employee | $-5.62K |
| Employee Count | 10,218 |
| Asset Turnover | 0.59 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -170K |
| Effective Tax Rate | 0.3% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 1.3, so LifeStance Health's price volatility has been higher than the market average.
| Beta | 1.3 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 6.95 |
| 200-Day Moving Average | 6.97 |
| Relative Strength Index (RSI) | 43.98 |
| Average Volume (20 Days) | 1.78M |
Income Statement
In the last 12 months, LifeStance Health had revenue of 1.25B and earned -57.44M in profits. Earnings per share was -0.15.
| Revenue | 1.25B |
| Gross Profit | 402.4M |
| Operating Income | -31.61M |
| Net Income | -57.44M |
| EBITDA | 39.87M |
| EBIT | -31.08M |
| Earnings Per Share (EPS) | -0.15 |
Balance Sheet
The company has 154.57M in cash and 485.19M in debt, giving a net cash position of -330.62M.
| Cash & Cash Equivalents | 154.57M |
| Total Debt | 485.19M |
| Net Cash | -330.62M |
| Retained Earnings | -818.29M |
| Total Assets | 2.12B |
| Working Capital | 83.62M |
Cash Flow
In the last 12 months, operating cash flow was 107.26M and capital expenditures -21.57M, giving a free cash flow of 85.69M.
| Operating Cash Flow | 107.26M |
| Capital Expenditures | -21.57M |
| Free Cash Flow | 85.69M |
| FCF Per Share | 0.23 |
Margins
Gross margin is 32.17%, with operating and profit margins of -2.53% and -4.59%.
| Gross Margin | 32.17% |
| Operating Margin | -2.53% |
| Pretax Margin | -4.61% |
| Profit Margin | -4.59% |
| EBITDA Margin | 3.19% |
| EBIT Margin | -2.53% |
| FCF Margin | 6.85% |
Dividends & Yields
LFST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for LFST is $8, which is 22.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $8 |
| Price Target Difference | 22.5% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Scores
| Altman Z-Score | 2.29 |
| Piotroski F-Score | 6 |